Increased concentration of hydrogen peroxide (H2 O2 ) in expired breath condensate of patients with lung cancer and stable chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 247s Year: 2001
Pretreatment levels of VEGF and 8-isoprostane in exhaled breath condensate (EBC) and serum of lung cancer patients Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology Year: 2008
Pretreatment levels of TNF-α in serum and exhaled breath condensate in patients with lung cancer Source: Annual Congress 2007 - Biology of thoracic malignancies Year: 2007
Elevated concentration of exhaled hydrogen peroxide in patients with asthma and COPD Source: Eur Respir J 2001; 18: Suppl. 33, 166s Year: 2001
Concentrations of the hydrogen peroxide and nitrite in exhaled breath condensate as markers of inflammatory lung diseases Source: Annual Congress 2008 - COPD Year: 2008
N-acetylcysteine reduces 8-isoprostane levels in exhaled breath condensate and serum of COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 13s Year: 2005
Relationship between hydrogen peroxide levels in exhaled breath condensate and long term changes in small airway function of patients with asthma Source: Eur Respir J 2007; 30: Suppl. 51, 585s Year: 2007
Relationships between the concentrations of NO, IL1β, TNF-α, IL-6 in exhaled breath condensate (EBC) and lung function in patient with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 61s Year: 2005
Exercise increases the hydrogen peroxide release in exhaled breath condensate Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases Year: 2012
The concentration of hydrogen peroxide in exhaled breath condensate (EBC) depends on food intake and increases during the day Source: Eur Respir J 2006; 28: Suppl. 50, 283s Year: 2006
Quantitative analysis of 8-isoprostane and hydrogen peroxide in exhaled breath condensate Source: Eur Respir J 2004; 23: 189-192 Year: 2004
A new method for measuring hydrogen peroxide concentration in exhaled air in stable COPD patients: reproducibilityand stability Source: Eur Respir J 2001; 18: Suppl. 33, 460s Year: 2001
Nitrite concentration in exhaled breath condensate correlates with markers of lung overdistension in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 317s Year: 2004
The dynamic of pH, hydrogen peroxide and nitrite in exhaled breath condensate from patients with COPD and asthma exacerbation Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010
Increased of TNF-α Levels in breath condensate and in serum of COPD subjects Source: Eur Respir J 2003; 22: Suppl. 45, 448s Year: 2003
Detection of angiogenesis, antiangiogenesis and hypoxia related molecules in plasma and exhaled breath condensate (EBC): evaluation of potential biomarkers Source: Annual Congress 2009 - Airway inflammation and host defence Year: 2009
Increased lactate concentrations in exhaled breath condensate (EBC) in COPD Source: Eur Respir J 2007; 30: Suppl. 51, 584s Year: 2007
Time course of exhaled hydrogen peroxide (H2 O2 ) and nitric oxide (eNO) during chemotherapy in patients with lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 92s Year: 2005
Correlation of H2 O2 , pH and nitrite/nitrate in exhaled breath condensate and systemic inflammatory parameters during and after acute COPD exacerbation Source: Eur Respir J 2005; 26: Suppl. 49, 349s Year: 2005
Acute neutrophilic airway inflammation is associated with a decrease in pulmonary ascorbic acid concentration but not an elevation of exhaled hydrogen peroxide Source: Eur Respir J 2004; 24: Suppl. 48, 596s Year: 2004